Skip to main content
SpringerLink
Log in

Brazil breaks efavirenz patent, hailed as victory by AHF

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. AIDS Healthcare Foundation.Brazil Breaks Merck Drug Patent in Major Victory for AIDS Activism, Says AHF. Media Release: 4 May 2007. Available from: URL: http://www.prnewswire.com

  2. Merck & Co Inc.Merck & Co., Inc. Statement on Brazilian Government's Decision To Issue Compulsory License for STOCRIN™. Media Release: 5 May 2007. Available from: URL: http://www.merck.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brazil breaks efavirenz patent, hailed as victory by AHF. Pharmacoecon. Outcomes News 528, 10 (2007). https://doi.org/10.2165/00151234-200705280-00024

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705280-00024

Keywords

Search

Navigation